MENU
REPL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Replimune Group (REPL) Ownership - Who owns Replimune Group?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
960.41M
P/E Ratio
N/A
Total Cash
432.06M
Projected Growth
N/A
Total Debt
76.12M
Revenue
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash/Share
5.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
REPL
Capitalization
960M
P/E Ratio
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash
432M
Total Cash/Share
5.61
Total Debt
76.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
381M
P/B Ratio
2.52
Cash Flow
N/A
Earnings
-3.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
68K
Current Ratio
10.11
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-202.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.17
Shares Held By Institutions
966M
Shares Outstanding - Current
77M
Total Liabilities
117M
Total Volume MTD
N/A
Value
N/A
Gain YTD
48.161
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of oncolytic immunotherapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com